FDA approves first self-administered flu vaccine
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
Nasal Flu Vaccine Is Approved for At-Home Use
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
Full list of severe allergic reactions to the flu vaccine and when to call 999
chronic (long-term) respiratory disease, such as asthma (requires continuous or repeated use of inhaled or systemic steroids ...
Zacks.com on MSN7h
Roche Antiviral Drug Reduces Transmission in Late-stage Study
Roche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza. The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, ...
Health Affairs8h
How Policy Makers Can Act Now To Prevent An Avian Influenza Pandemic
It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...
NHS staff sickness: the top 10 reasons that NHS staff are missing work
The leading cause for NHS staff absences was psychiatric illnesses, with 25.6% naming it as their reason for taking time off.
Pharmabiz17h
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...